Alterity Therapeutics Announced Positive Interim Data From The ATH434-202 Open-label Phase 2 Clinical Trial In Patients With Multiple System Atrophy
Alterity Therapeutics Announced Positive Interim Data From The ATH434-202 Open-label Phase 2 Clinical Trial In Patients With Multiple System Atrophy
alterity therapeutics宣佈在多系統萎縮症患者中進行的ATH434-202開放標籤II期臨床試驗的陽性中期數據。
Alterity Therapeutics Announced Positive Interim Data From The ATH434-202 Open-label Phase 2 Clinical Trial In Patients With Multiple System Atrophy
alterity therapeutics宣佈在多系統萎縮症患者中進行的ATH434-202開放標籤II期臨床試驗的陽性中期數據。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。